Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV003337192 | SCV004045419 | pathogenic | Familial cancer of breast | 2023-06-06 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |
Ambry Genetics | RCV004334131 | SCV005029191 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-02-08 | criteria provided, single submitter | clinical testing | The c.2341delA pathogenic mutation, located in coding exon 15 of the BRIP1 gene, results from a deletion of one nucleotide at nucleotide position 2341, causing a translational frameshift with a predicted alternate stop codon (p.T781Qfs*2). This variant was reported in 1 of 1007 individuals with a personal history of breast cancer (Walsh T et al. JAMA Oncol, 2017 Dec;3:1647-1653). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |